Standard BioTools Inc. Net Income
Standard BioTools Inc. (LAB) reported Net Income of -$26.76 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2026-08-05
- Standard BioTools Inc. net income (loss) attributable to parent for the quarter ending 2026-06-30 was -$26.76M.
- Standard BioTools Inc. net income (loss) attributable to parent for the quarter ending 2026-03-31 was $127.07M.
- Standard BioTools Inc. net income (loss) attributable to parent for the quarter ending 2025-12-31 was $19.28M.
- Standard BioTools Inc. net income (loss) attributable to parent for the quarter ending 2025-09-30 was -$34.69M.
- Standard BioTools Inc. net income (loss) attributable to parent for fiscal 2020 was -$53.02M.
- Standard BioTools Inc. net income (loss) attributable to parent for fiscal 2019 was -$64.79M.
- Standard BioTools Inc. net income (loss) attributable to parent for fiscal 2018 was -$59.01M.
- Standard BioTools Inc. net income (loss) attributable to parent for fiscal 2017 was -$60.53M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$26.76M 10-Q · filed 2026-08-05 | $100.31M 10-Q · filed 2026-08-05 | $119.59M derived: sum of 3 quarters · filed 2026-08-05 | $84.91M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $127.07M 10-Q · filed 2026-08-05 | $146.35M derived: sum of 2 quarters · filed 2026-08-05 | $111.66M derived: sum of 3 quarters · filed 2026-08-05 | $78.20M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $19.28M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-27 | -$15.40M derived: sum of 2 quarters · filed 2026-04-27 | -$48.86M derived: sum of 3 quarters · filed 2026-08-05 | -$74.90M DEF 14A · filed 2026-04-27 |
| 2025-09-30 | -$34.69M 10-Q · filed 2025-11-04 | -$68.15M derived: sum of 2 quarters · filed 2026-08-05 | -$94.18M 10-Q · filed 2025-11-04 | -$128.25M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$33.46M 10-Q · filed 2026-08-05 | -$59.49M 10-Q · filed 2026-08-05 | -$93.56M derived: sum of 3 quarters · filed 2026-08-05 | -$120.50M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$26.03M 10-Q · filed 2026-08-05 | -$60.10M derived: sum of 2 quarters · filed 2026-08-05 | -$87.04M derived: sum of 3 quarters · filed 2026-08-05 | -$132.76M derived: sum of 4 quarters · filed 2026-08-05 |
| 2024-12-31 | -$34.07M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-27 | -$61.01M derived: sum of 2 quarters · filed 2026-04-27 | -$106.73M derived: sum of 3 quarters · filed 2026-04-27 | -$138.88M DEF 14A · filed 2026-04-27 |
| 2024-09-30 | -$26.94M 10-Q · filed 2025-11-04 | -$72.66M derived: sum of 2 quarters · filed 2025-11-04 | -$104.81M 10-Q · filed 2025-11-04 | -$124.59M derived: sum of 4 quarters · filed 2026-04-27 |
| 2024-06-30 | -$45.72M 10-Q · filed 2025-11-04 | -$77.88M 10-Q · filed 2025-08-15 | -$97.65M derived: sum of 3 quarters · filed 2026-04-27 | -$118.65M derived: sum of 4 quarters · filed 2026-04-27 |
| 2024-03-31 | -$32.16M 10-Q · filed 2025-11-04 | -$51.93M derived: sum of 2 quarters · filed 2026-04-27 | -$72.93M derived: sum of 3 quarters · filed 2026-04-27 | -$89.97M derived: sum of 4 quarters · filed 2026-04-27 |
| 2023-12-31 | -$19.78M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-27 | -$40.77M derived: sum of 2 quarters · filed 2026-04-27 | -$57.81M derived: sum of 3 quarters · filed 2026-04-27 | -$74.66M DEF 14A · filed 2026-04-27 |
| 2023-09-30 | -$21.00M 10-Q · filed 2024-11-06 | -$38.04M derived: sum of 2 quarters · filed 2024-11-06 | -$54.88M 10-Q · filed 2024-11-06 | -$75.72M derived: sum of 4 quarters · filed 2026-04-27 |
| 2023-06-30 | -$17.04M 10-Q · filed 2024-11-06 | -$33.88M 10-Q · filed 2024-08-06 | -$54.73M derived: sum of 3 quarters · filed 2026-04-27 | -$84.15M derived: sum of 4 quarters · filed 2026-04-27 |
| 2023-03-31 | -$16.84M 10-Q · filed 2024-11-06 | -$37.69M derived: sum of 2 quarters · filed 2026-04-27 | -$67.11M derived: sum of 3 quarters · filed 2026-04-27 | -$130.65M derived: sum of 4 quarters · filed 2026-04-27 |
| 2022-12-31 | -$20.84M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-27 | -$50.27M derived: sum of 2 quarters · filed 2026-04-27 | -$113.81M derived: sum of 3 quarters · filed 2026-04-27 | -$190.10M DEF 14A · filed 2026-04-27 |
| 2022-09-30 | -$29.43M 10-Q · filed 2023-11-07 | -$92.97M derived: sum of 2 quarters · filed 2023-11-07 | -$169.25M 10-Q · filed 2023-11-07 | -$178.68M derived: sum of 4 quarters · filed 2026-04-27 |
| 2022-06-30 | -$63.54M 10-Q · filed 2023-11-07 | -$139.83M 10-Q · filed 2023-08-08 | -$149.26M derived: sum of 3 quarters · filed 2026-04-27 | -$163.10M derived: sum of 4 quarters · filed 2026-04-27 |
| 2022-03-31 | -$76.29M 10-Q · filed 2023-11-07 | -$85.72M derived: sum of 2 quarters · filed 2026-04-27 | -$99.56M derived: sum of 3 quarters · filed 2026-04-27 | -$116.70M derived: sum of 4 quarters · filed 2026-04-27 |
| 2021-12-31 | -$9.43M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-27 | -$23.27M derived: sum of 2 quarters · filed 2026-04-27 | -$40.41M derived: sum of 3 quarters · filed 2026-04-27 | -$59.24M DEF 14A · filed 2026-04-27 |
| 2021-09-30 | -$13.84M 10-Q · filed 2022-11-09 | -$30.99M derived: sum of 2 quarters · filed 2022-11-09 | -$49.81M 10-Q · filed 2022-11-09 | -$67.83M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | -$17.14M 10-Q · filed 2022-11-09 | -$35.96M 10-Q · filed 2022-08-09 | -$53.99M derived: sum of 3 quarters · filed 2022-11-09 | -$59.99M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-03-31 | -$18.82M 10-Q · filed 2022-11-09 | -$36.85M derived: sum of 2 quarters · filed 2022-11-09 | -$42.85M derived: sum of 3 quarters · filed 2022-11-09 | -$55.86M derived: sum of 4 quarters · filed 2022-11-09 |
| 2020-12-31 | -$18.03M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | -$24.02M derived: sum of 2 quarters · filed 2022-03-08 | -$37.04M derived: sum of 3 quarters · filed 2022-03-08 | -$53.02M 10-K · filed 2022-03-08 |
| 2020-09-30 | -$6.00M 10-Q · filed 2021-11-09 | -$19.01M derived: sum of 2 quarters · filed 2021-11-09 | -$34.99M 10-Q · filed 2021-11-09 | -$47.68M derived: sum of 4 quarters · filed 2022-03-08 |
| 2020-06-30 | -$13.02M 10-Q · filed 2021-11-09 | -$29.00M 10-Q · filed 2021-08-06 | -$41.68M derived: sum of 3 quarters · filed 2022-03-08 | -$54.57M derived: sum of 4 quarters · filed 2022-03-08 |
| 2020-03-31 | -$15.98M 10-Q · filed 2021-11-09 | -$28.66M derived: sum of 2 quarters · filed 2022-03-08 | -$41.55M derived: sum of 3 quarters · filed 2022-03-08 | -$55.30M derived: sum of 4 quarters · filed 2022-03-08 |
| 2019-12-31 | -$12.69M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | -$25.57M derived: sum of 2 quarters · filed 2022-03-08 | -$39.33M derived: sum of 3 quarters · filed 2022-03-08 | -$64.79M 10-K · filed 2022-03-08 |
| 2019-09-30 | -$12.89M 10-Q · filed 2020-11-09 | -$26.64M derived: sum of 2 quarters · filed 2020-11-09 | -$52.10M 10-Q · filed 2020-11-09 | -$66.88M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | -$13.75M 10-Q · filed 2020-11-09 | -$39.22M 10-Q · filed 2020-08-07 | -$53.99M derived: sum of 3 quarters · filed 2021-02-25 | -$68.74M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | -$25.46M 10-Q · filed 2020-11-09 | -$40.24M derived: sum of 2 quarters · filed 2021-02-25 | -$54.99M derived: sum of 3 quarters · filed 2021-02-25 | -$71.23M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | -$14.78M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$29.52M derived: sum of 2 quarters · filed 2021-02-25 | -$45.77M derived: sum of 3 quarters · filed 2021-02-25 | -$59.01M 10-K · filed 2021-02-25 |
| 2018-09-30 | -$14.75M 10-Q · filed 2019-11-08 | -$30.99M derived: sum of 2 quarters · filed 2019-11-08 | -$44.24M 10-Q · filed 2019-11-08 | -$54.70M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | -$16.24M 10-Q · filed 2019-11-08 | -$29.49M 10-Q · filed 2019-08-07 | -$39.95M derived: sum of 3 quarters · filed 2020-02-27 | -$55.89M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | -$13.25M 10-Q · filed 2019-11-08 | -$23.70M derived: sum of 2 quarters · filed 2020-02-27 | -$39.65M derived: sum of 3 quarters · filed 2020-02-27 | -$56.58M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | -$10.46M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$26.40M derived: sum of 2 quarters · filed 2020-02-27 | -$43.33M derived: sum of 3 quarters · filed 2020-02-27 | -$60.53M 10-K · filed 2020-02-27 |
| 2017-09-30 | -$15.94M 10-Q · filed 2018-11-06 | -$32.88M derived: sum of 2 quarters · filed 2018-11-06 | -$50.08M 10-Q · filed 2018-11-06 | -$67.78M derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-06-30 | -$16.93M 10-Q · filed 2018-08-08 | -$34.13M 10-Q · filed 2018-08-08 | -$51.83M derived: sum of 3 quarters · filed 2019-03-18 | -$71.62M derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-03-31 | -$17.20M 10-Q · filed 2018-05-08 | -$34.90M derived: sum of 2 quarters · filed 2019-03-18 | -$54.69M derived: sum of 3 quarters · filed 2019-03-18 | -$73.30M derived: sum of 4 quarters · filed 2019-03-18 |
| 2016-12-31 | -$17.70M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | -$37.48M derived: sum of 2 quarters · filed 2019-03-18 | -$56.10M derived: sum of 3 quarters · filed 2019-03-18 | -$75.98M 10-K · filed 2019-03-18 |
| 2016-09-30 | -$19.79M 10-Q · filed 2017-11-07 | -$38.41M derived: sum of 2 quarters · filed 2017-11-07 | -$58.29M 10-Q · filed 2017-11-07 | -$71.17M derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-06-30 | -$18.62M 10-Q · filed 2017-08-08 | -$38.50M 10-Q · filed 2017-08-08 | -$51.38M derived: sum of 3 quarters · filed 2018-03-08 | -$60.65M derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-03-31 | -$19.88M 10-Q · filed 2017-05-09 | -$32.76M derived: sum of 2 quarters · filed 2018-03-08 | -$42.03M derived: sum of 3 quarters · filed 2018-03-08 | -$57.27M derived: sum of 4 quarters · filed 2018-03-08 |
| 2015-12-31 | -$12.88M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | -$22.15M derived: sum of 2 quarters · filed 2018-03-08 | -$37.38M derived: sum of 3 quarters · filed 2018-03-08 | -$53.31M 10-K · filed 2018-03-08 |
| 2015-09-30 | -$9.27M 10-Q · filed 2016-11-09 | -$24.50M derived: sum of 2 quarters · filed 2016-11-09 | -$40.44M 10-Q · filed 2016-11-09 | -$51.38M derived: sum of 4 quarters · filed 2017-03-03 |
| 2015-06-30 | -$15.24M 10-Q · filed 2016-08-09 | -$31.17M 10-Q · filed 2016-08-09 | -$42.11M derived: sum of 3 quarters · filed 2017-03-03 | -$55.90M derived: sum of 4 quarters · filed 2017-03-03 |
| 2015-03-31 | -$15.93M 10-Q · filed 2016-05-09 | -$26.88M derived: sum of 2 quarters · filed 2017-03-03 | -$40.66M derived: sum of 3 quarters · filed 2017-03-03 | -$53.35M derived: sum of 4 quarters · filed 2017-03-03 |
| 2014-12-31 | -$10.94M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | -$24.73M derived: sum of 2 quarters · filed 2017-03-03 | -$37.42M derived: sum of 3 quarters · filed 2017-03-03 | -$52.83M 10-K · filed 2017-03-03 |
| 2014-09-30 | -$13.79M 10-Q · filed 2015-11-09 | -$26.47M derived: sum of 2 quarters · filed 2015-11-09 | -$41.89M 10-Q · filed 2015-11-09 | -$46.53M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | -$12.68M 10-Q · filed 2015-08-10 | -$28.10M 10-Q · filed 2015-08-10 | -$32.74M derived: sum of 3 quarters · filed 2016-02-29 | -$37.02M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | -$15.41M 10-Q · filed 2015-05-11 | -$20.06M derived: sum of 2 quarters · filed 2016-02-29 | -$24.34M derived: sum of 3 quarters · filed 2016-02-29 | -$28.39M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | -$4.64M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$8.93M derived: sum of 2 quarters · filed 2016-02-29 | -$12.97M derived: sum of 3 quarters · filed 2016-02-29 | -$16.53M 10-K · filed 2016-02-29 |
| 2013-09-30 | -$4.29M 10-Q · filed 2014-11-06 | -$8.33M derived: sum of 2 quarters · filed 2014-11-06 | -$11.88M 10-Q · filed 2014-11-06 | -$15.48M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-06-30 | -$4.05M 10-Q · filed 2014-08-04 | -$7.60M 10-Q · filed 2014-08-04 | -$11.20M derived: sum of 3 quarters · filed 2015-02-26 | -$15.35M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-03-31 | -$3.55M 10-Q · filed 2014-05-12 | -$7.15M derived: sum of 2 quarters · filed 2015-02-26 | -$11.30M derived: sum of 3 quarters · filed 2015-02-26 | -$15.88M derived: sum of 4 quarters · filed 2015-02-26 |
| 2012-12-31 | -$3.60M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | -$7.75M derived: sum of 2 quarters · filed 2015-02-26 | -$12.33M derived: sum of 3 quarters · filed 2015-02-26 | -$19.02M 10-K · filed 2015-02-26 |
| 2012-09-30 | -$4.15M 10-Q · filed 2013-11-07 | -$8.73M derived: sum of 2 quarters · filed 2013-11-07 | -$15.42M 10-Q · filed 2013-11-07 | -$18.88M derived: sum of 4 quarters · filed 2014-03-12 |
| 2012-06-30 | -$4.58M 10-Q · filed 2013-08-07 | -$11.27M 10-Q · filed 2013-08-07 | -$14.73M derived: sum of 3 quarters · filed 2014-03-12 | -$19.22M derived: sum of 4 quarters · filed 2014-03-12 |
| 2012-03-31 | -$6.69M 10-Q · filed 2013-05-09 | -$10.15M derived: sum of 2 quarters · filed 2014-03-12 | -$14.64M derived: sum of 3 quarters · filed 2014-03-12 | -$21.82M derived: sum of 4 quarters · filed 2014-03-12 |
| 2011-12-31 | -$3.46M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-12 | -$7.95M derived: sum of 2 quarters · filed 2014-03-12 | -$15.13M derived: sum of 3 quarters · filed 2014-03-12 | -$22.47M 10-K · filed 2014-03-12 |
| 2011-09-30 | -$4.49M 10-Q · filed 2012-11-09 | -$11.68M derived: sum of 2 quarters · filed 2012-11-09 | -$19.01M 10-Q · filed 2012-11-09 | -$22.09M derived: sum of 4 quarters · filed 2013-03-12 |
| 2011-06-30 | -$7.19M 10-Q · filed 2012-08-14 | -$14.52M 10-Q · filed 2012-08-14 | -$17.60M derived: sum of 3 quarters · filed 2013-03-12 | -$20.98M derived: sum of 4 quarters · filed 2013-03-12 |
| 2011-03-31 | -$7.34M 10-Q · filed 2012-05-15 | -$10.42M derived: sum of 2 quarters · filed 2013-03-12 | -$13.80M derived: sum of 3 quarters · filed 2013-03-12 | -$18.61M derived: sum of 4 quarters · filed 2013-03-12 |
| 2010-12-31 | -$3.08M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12 | -$6.46M derived: sum of 2 quarters · filed 2013-03-12 | -$11.28M derived: sum of 3 quarters · filed 2013-03-12 | -$16.90M 10-K · filed 2013-03-12 |
| 2010-09-30 | -$3.38M 10-Q · filed 2011-11-14 | -$8.20M derived: sum of 2 quarters · filed 2011-11-14 | -$13.82M 10-Q · filed 2011-11-14 | |
| 2010-06-30 | -$4.82M 10-Q · filed 2011-08-09 | -$10.44M 10-Q · filed 2011-08-09 | ||
| 2009-12-31 | -$19.13M 10-K · filed 2012-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |